Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665

Rebecca DeBoerDepartment of Medicine, University of Chicago Medical Center, Chicago, IL, USA;

Gregory KovalDepartment of Medicine, University of Chicago Medical Center, Chicago, IL, USA;

Flora MulkeyAlliance Statistics and Data Center, Duke University Medical Center, Durham, NC, USA;

Meir WetzlerRoswell Park Cancer Institute, Buffalo, NY, USA;

Steven DevineThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;

Guido MarcucciCity of Hope Comprehensive Cancer Center, Duarte, CA, USA;

Richard M. StoneDana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;

Richard A. LarsonDepartment of Medicine, University of Chicago Medical Center, Chicago, IL, USA;

Clara D. BloomfieldThe Ohio State University Comprehensive Cancer Center, Columbus, OH, USA;

Susan GeyerHealth Informatics Institute, University of South Florida, Tampa, FL, USA;

Charles G. MullighanSt. Jude Children’s Research Hospital, Memphis, TN, USA

Wendy StockDepartment of Medicine, University of Chicago Medical Center, Chicago, IL, USA; Correspondence[email protected]

Your download is now in progress and you may close this window